225 related articles for article (PubMed ID: 32326614)
1. Large Neutral Amino Acids (LNAAs) Supplementation Improves Neuropsychological Performances in Adult Patients with Phenylketonuria.
Scala I; Riccio MP; Marino M; Bravaccio C; Parenti G; Strisciuglio P
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326614
[TBL] [Abstract][Full Text] [Related]
2. Large neutral amino acid supplementation as an alternative to the phenylalanine-restricted diet in adults with phenylketonuria: evidence from adult Pah-enu2 mice.
van Vliet D; van der Goot E; Bruinenberg VM; van Faassen M; de Blaauw P; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
J Nutr Biochem; 2018 Mar; 53():20-27. PubMed ID: 29175141
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model.
van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Pascucci T; Puglisi-Allegra S; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
Am J Clin Nutr; 2016 Nov; 104(5):1292-1300. PubMed ID: 27655443
[TBL] [Abstract][Full Text] [Related]
4. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
[TBL] [Abstract][Full Text] [Related]
5. The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with Phenylketonuria.
Burlina AP; Cazzorla C; Massa P; Loro C; Gueraldi D; Burlina AB
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32674279
[TBL] [Abstract][Full Text] [Related]
6. The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
Romani C; Palermo L; MacDonald A; Limback E; Hall SK; Geberhiwot T
Neuropsychology; 2017 Mar; 31(3):242-254. PubMed ID: 28240926
[TBL] [Abstract][Full Text] [Related]
7. Large neutral amino acids in daily practice.
Ahring KK
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S187-90. PubMed ID: 20300852
[TBL] [Abstract][Full Text] [Related]
8. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
[TBL] [Abstract][Full Text] [Related]
9. Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults.
Moats RA; Moseley KD; Koch R; Nelson M
Pediatrics; 2003 Dec; 112(6 Pt 2):1575-9. PubMed ID: 14654668
[TBL] [Abstract][Full Text] [Related]
10. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
[TBL] [Abstract][Full Text] [Related]
11. The Benefit of Large Neutral Amino Acid Supplementation to a Liberalized Phenylalanine-Restricted Diet in Adult Phenylketonuria Patients: Evidence from Adult
van Vliet D; van der Goot E; van Ginkel WG; van Faassen MHJR; de Blaauw P; Kema IP; Martinez A; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31546852
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
[TBL] [Abstract][Full Text] [Related]
13. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
[TBL] [Abstract][Full Text] [Related]
14. Emotional health in early-treated adults with phenylketonuria (PKU): Relationship with cognitive abilities and blood phenylalanine.
Palermo L; MacDonald A; Limback E; Robertson L; Howe S; Geberhiwot T; Romani C
J Clin Exp Neuropsychol; 2020 Mar; 42(2):142-159. PubMed ID: 31790339
[No Abstract] [Full Text] [Related]
15. Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acids.
Concolino D; Mascaro I; Moricca MT; Bonapace G; Matalon K; Trapasso J; Radhakrishnan G; Ferrara C; Matalon R; Strisciuglio P
Eur J Clin Nutr; 2017 Jan; 71(1):51-55. PubMed ID: 27623981
[TBL] [Abstract][Full Text] [Related]
16. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.
Pietz J; Kreis R; Rupp A; Mayatepek E; Rating D; Boesch C; Bremer HJ
J Clin Invest; 1999 Apr; 103(8):1169-78. PubMed ID: 10207169
[TBL] [Abstract][Full Text] [Related]
17. Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria.
Scala I; Concolino D; Nastasi A; Esposito G; Crisci D; Sestito S; Ferraro S; Albano L; Ruoppolo M; Parenti G; Strisciuglio P
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836270
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine monitoring in children with early and continuously treated phenylketonuria: results of an international practice survey.
Sharman R; Sullivan KA; Young RM; McGill JJ
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S417-20. PubMed ID: 20882350
[TBL] [Abstract][Full Text] [Related]
19. Large neutral amino acids in the treatment of phenylketonuria (PKU).
Matalon R; Michals-Matalon K; Bhatia G; Grechanina E; Novikov P; McDonald JD; Grady J; Tyring SK; Guttler F
J Inherit Metab Dis; 2006 Dec; 29(6):732-8. PubMed ID: 16988900
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
